SCHEMBL28009485

SCHEMBL28009485

ClC(Cl)Oc1ccncn1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.38
P2RX7 Q99572 1/20 0.33
RXRA P19793 2/20 0.33
GRIN1 Q05586 2/20 0.33
GRIN2B Q13224 2/20 0.33
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27558822 0.78 HSP90AA1 (0.43) HSP90AA1P2RX7RXRAGRIN1GRIN2B
SCHEMBL8138898 0.78 ALDH1A1 (0.39) HSP90AA1
SCHEMBL27772313 0.78 HSP90AA1 (0.38) HSP90AA1P2RX7RXRAGRIN1GRIN2B
SCHEMBL9963206 0.75 HSP90AA1 (0.35) HSP90AA1RXRAGRIN1GRIN2B
SCHEMBL27958375 0.75
SCHEMBL11196649 0.74 HSP90AA1 (0.46) HSP90AA1P2RX7CYP19A1
SCHEMBL27431126 0.72 RXRA (0.35) HSP90AA1P2RX7RXRAGRIN1GRIN2B
SCHEMBL5883850 0.71
SCHEMBL8140461 0.70
SCHEMBL29445955 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106243090-A As 2 (phenyl or the pyridine 3 base) aminopyridine derivative for treating Parkinsonian kinases LRRK2 regulator 霍夫曼-拉罗奇有限公司 2016-12-21 CN disclosed
CN-103958503-B 2- (phenyl or pyridin-3-yl) aminopyrimidine derivatives as kinase LRRK2 modulators for the treatment of Parkinson's disease 霍夫曼-拉罗奇有限公司 2016-09-28 CN disclosed
CN-103958498-B Aminopyrimidine derivatives as LRRK2 modulators 霍夫曼-拉罗奇有限公司 2016-09-07 CN disclosed
CN-105837519-A AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS 霍夫曼-拉罗奇有限公司 2016-08-10 CN disclosed
CN-105801493-A 2-phenylaminopyrimidine derivatives as kinase LRRK2 modulators for the treatment of Parkinson's disease 霍夫曼-拉罗奇有限公司 2016-07-27 CN disclosed
CN-103313978-B Pyrazole aminopyrimidine derivatives as LRRK2 modulators HOFFMANN LA ROCHE 2015-04-15 CN disclosed